Genprex, Inc. (GNPX): Total Assets
$10.16M
As of 2025-12-31
$17.14M
As of 2026-06-30
-26.0%
3-year compound annual growth
-20.2%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.16M | +146.3% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $4.12M | -61.3% | 2026-03-30, Balance as of period end |
| 2023-12-31 | $10.67M | -57.5% | 2025-04-01, Balance as of period end |
| 2022-12-31 | $25.09M | n/a | 2024-04-01, Balance as of period end |
| 2022-09-30 | $29.95M | n/a | 2023-03-31, Balance as of period end |
| 2022-06-30 | $34.57M | n/a | 2023-03-31, Balance as of period end |
| 2021-12-31 | $42.86M | +36.6% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $31.37M | +787.5% | 2022-03-30, Balance as of period end |
| 2019-12-31 | $3.53M | -61.9% | 2021-03-26, Balance as of period end |
| 2018-12-31 | $9.27M | +635.9% | 2020-03-30, Balance as of period end |
| 2017-12-31 | $1.26M | -34.1% | 2019-04-01, Balance as of period end |
| 2016-12-31 | $1.91M | n/a | 2018-04-17, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Genprex, Inc. (GNPX) | 2025-12-31 | $10.16M | +146.3% |
| Oragenics Inc (OGEN) | 2025-12-31 | $10.07M | +583.7% |
| Medicus Pharma Ltd. (MDCX) | 2025-12-31 | $10.06M | +78.2% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $10.26M | -59.9% |
| Korsana Biosciences, Inc. (KRSA) | 2025-12-31 | $9.98M | +4.3% |
| Lunai Bioworks Inc. (LNAI) | 2026-06-30 | $9.94M | +20.8% |
| Nanoviricides, Inc. (NNVC) | 2026-06-30 | $9.87M | +11.9% |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | 2025-12-31 | $10.48M | +318.0% |
| Traws Pharma, Inc. (TRAW) | 2025-12-31 | $10.62M | -57.5% |
Compare GNPX, OGEN, MDCX, LGVN side by side · Screen every company in Pharmaceutical Preparations ↗